[HTML][HTML] Diagnosis and management of migraine in ten steps

AK Eigenbrodt, H Ashina, S Khan, HC Diener… - Nature Reviews …, 2021 - nature.com
Migraine is a disabling primary headache disorder that directly affects more than one billion
people worldwide. Despite its widespread prevalence, migraine remains under-diagnosed …

[HTML][HTML] Applying a biopsychosocial model to migraine: rationale and clinical implications

C Rosignoli, R Ornello, A Onofri, V Caponnetto… - The journal of headache …, 2022 - Springer
Migraine is a complex condition in which genetic predisposition interacts with other
biological and environmental factors determining its course. A hyperresponsive brain cortex …

[HTML][HTML] Exploring novel therapeutic targets in the common pathogenic factors in migraine and neuropathic pain

J Tajti, D Szok, A Csáti, Á Szabó, M Tanaka… - International Journal of …, 2023 - mdpi.com
Migraine and neuropathic pain (NP) are both painful, disabling, chronic conditions which
exhibit some symptom similarities and are thus considered to share a common etiology. The …

Amylin analog pramlintide induces migraine‐like attacks in patients

H Ghanizada, MAM Al‐Karagholi, CS Walker… - Annals of …, 2021 - Wiley Online Library
Objective Migraine is a prevalent and disabling neurological disease. Its genesis is poorly
understood, and there remains unmet clinical need. We aimed to identify mechanisms and …

[HTML][HTML] Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study

CK Cullum, TP Do, M Ashina, L Bendtsen… - The Journal of …, 2022 - Springer
Background Clinical trials have shown that erenumab is effective and well-tolerated for the
preventive treatment of chronic migraine. To extend the results from clinical trials, we …

[HTML][HTML] Cognitive behavioral therapy for migraine headache: a systematic review and meta-analysis

J Bae, HK Sung, NY Kwon, HY Go, T Kim, SM Shin… - Medicina, 2021 - mdpi.com
Background and Objectives: Migraine headaches are chronic neurological diseases that
reduce the quality of life by causing severe headaches and autonomic nervous system …

New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy

MJ Lee, MAM Al-Karagholi, U Reuter - Cephalalgia, 2023 - journals.sagepub.com
Background Monoclonal antibodies against calcitonin gene-related peptide (CGRP) or its
receptor (anti-CGRP (-R) mAbs) and small-molecule CGRP receptor antagonists (gepants) …

A systematic review and meta-analysis of voxel-based morphometric studies of migraine

X Zhang, J Zhou, M Guo, S Cheng, Y Chen, N Jiang… - Journal of …, 2023 - Springer
Objectives To comprehensively summarize and meta-analyze the concurrence across voxel-
based morphometric (VBM) neuroimaging studies of migraine. Methods Neuroimaging …

[HTML][HTML] TRPM8 contributes to sex dimorphism by promoting recovery of normal sensitivity in a mouse model of chronic migraine

D Alarcón-Alarcón, D Cabañero… - Nature …, 2022 - nature.com
TRPA1 and TRPM8 are transient receptor potential channels expressed in trigeminal
neurons that are related to pathophysiology in migraine models. Here we use a mouse …

[HTML][HTML] Migraine attacks are of peripheral origin: the debate goes on

TP Do, A Hougaard, G Dussor, KC Brennan… - The Journal of …, 2023 - Springer
Background Despite the pervasiveness of migraine, the underlying pathophysiological
mechanisms initiating migraine attacks are far from well understood and are matter of …